scispace - formally typeset
M

Mark E. Cooper

Researcher at University of Queensland

Publications -  1514
Citations -  141899

Mark E. Cooper is an academic researcher from University of Queensland. The author has contributed to research in topics: Diabetes mellitus & Diabetic nephropathy. The author has an hindex of 158, co-authored 1463 publications receiving 124887 citations. Previous affiliations of Mark E. Cooper include University of Cambridge & University of Adelaide.

Papers
More filters
Journal ArticleDOI

An Ongoing Study of Anemia Correction in Chronic Kidney Disease

TL;DR: To the Editor: Evidence-based medicine assimilates available data to direct decisions regarding the care of patients and extrapolations from epidemiologic observations and laboratory or clinical marke...
Journal ArticleDOI

Complementary effects of pravastatin and nicotinic acid in the treatment of combined hyperlipidaemia in diabetic and non-diabetic patients

TL;DR: Pravastatin and nicotinic acid in a lower-dose combination are more effective than pravastatatin alone in reducing levels of triglyceride and elevating those of HDL cholesterol and are moreeffective than nicotini acid alone in reduced total-cholesterol, triglycerides and LDL-ch cholesterol levels.
Journal ArticleDOI

40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004.

M Veitenhansl, +5467 more
- 01 Aug 2004 - 
Journal ArticleDOI

Renal microvascular injury in diabetes: RAGE and redox signaling

TL;DR: This review focuses on how ROS play a deleterious role in the diabetic kidney and how they are involved in crosstalk among various signaling pathways, ultimately leading to renal dysfunction and structural injury.